Actively Recruiting
Study of Radiology Manipulator Work Validation by the Radiologist
Led by Institut Paoli-Calmettes · Updated on 2025-03-25
87
Participants Needed
1
Research Sites
124 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this study is to evaluate the pre-filling work on target and non-target lesions, and the detection of any new lesions reported by the MEM trained in protocol evaluations, in a structured table to prepare the radiologist's work in interpreting RECIST 1.1 scans. To meet this objective, patients taking part in the CIMER study will first have been included in a research protocol requiring scans with RECIST 1.1 interpretation. The Baseline examination will be performed and interpreted according to RECIST 1.1 without informing the radiologist performing the reading that the patient is included in the study, so as not to introduce an interpretation bias. During the first evaluation. The investigating MEM alone will carry out a preliminary analysis of the first evaluation and will present his results to the radiologist in charge of the evaluation, who will validate the conformity of the results.
CONDITIONS
Official Title
Study of Radiology Manipulator Work Validation by the Radiologist
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 and over
- Patient included in a clinical research protocol in oncology for solid cancer including RECIST 1.1 interpretation
- Disease measurable according to RECIST 1.1
- Patient not objecting to study participation
- Member of a social security scheme, or beneficiary of such a scheme.
You will not qualify if you...
- Patients with lymphoma or leukemia
- Patient contraindicated to iodinated contrast media injection
- Person in an emergency situation, adult subject to a legal protection measure (major under guardianship, curatorship or safeguard of justice), or unable to express his/her non-opposition to participate in the study
- Unable to undergo medical follow-up for geographical, social or psychological reasons
- Patient with renal insufficiency or allergy during the trial no longer allowing injection of iodinated contrast medium
- Patient refusing iodinated PDC injection during the study
- Patient withdrawn from the study including scanner interpretation in Recist 1.1
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut PAoli Camettes
Marseille, Institut Paoli Calmettes, France, 13009
Actively Recruiting
Research Team
J
Jihane PAKRADOUNI, Pr
CONTACT
A
Allison Arthur, Mme
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here